Albany, NY -- (SBWIRE) -- 11/15/2018 -- The global hormonal contraceptives market is predicted to benefit from increasing awareness among consumers. In a report added by ResearchMoz.us, the global hormonal contraceptives market is broadly evaluated on the basis of competition, segmentation, and market dynamics. It bears the title "Hormonal Contraceptive Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026." Rising incidence of polycystic ovary syndrome (PCOS) and obesity and high technological advancement are foreseen to augment the demand in the global hormonal contraceptives market. Other factors that could improve the demand for hormonal contraceptives are increasing awareness about population control and women health problems such as delayed childbearing.
The global hormonal contraceptives market is expected to propel on the back of the implementation of a number family planning programs in developed economies. Such programs are usually backed by governments. However, there are some factors prognosticated to negatively affect the growth of the global hormonal contraceptives market. For instance, lack of social acceptance of hormonal contraceptives in emerging countries, side effects of using hormonal contraceptives, and alternative contraceptive methods could hamper the demand in the global market. Nevertheless, the rise in infertility rate is prophesied to create ample of opportunities in the global hormonal contraceptives market.
Get a Sample PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1920390
By distribution channel, the global hormonal contraceptives market is classified into e-commerce, gynecology/fertility clinics, and drug stores. Securing an over 40.0% share of the global hormonal contraceptives market in 2017, drug stores could show their dominance in the coming years. By hormones, the global hormonal contraceptives market sees a classification into combined hormones and progestin only. Among these, combined hormones are expected to take hold of a lion's share of the global hormonal contraceptives market.
By method, the global hormonal contraceptives market is divided into vaginal rings, intrauterine contraceptives, injectable contraceptives, transdermal patches, and oral contraceptives. Among these, oral contraceptives could take the driver's seat of the global hormonal contraceptives market. From a geographical perspective, the global hormonal contraceptives market is projected to find North America taking a leading position in terms of share. Rising at a decent CAGR, the region showcased its dominance in 2017. Some of the crucial factors supporting the North America hormonal contraceptives market are ease of use of the devices, increase in infertility rate, and increase in awareness about women health.
Europe could be another region with strong growth in the global hormonal contraceptives market. In terms of revenue growth, it could closely follow North America during the course of the forecast period 2018-2026. Increase in healthcare expenditure and fertility rate are expected to push the demand for hormonal contraceptives in the Europe market. The global hormonal contraceptives market marks the presence of top players such as Agile Therapeutics, Inc., Bayer AG, Afaxys, Inc., and Allergan.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG